Nirmatrelvir

CAS 2628280-40-8

Overview

Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor

Anant Labs manufacture and furnish high quality Nirmatrelvir impurities for global markets. Our Nirmatrelvir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Nirmatrelvir

CAS 2628280-40-8In Stock

Technical Data

CAS2628280-40-8

Mol. FormulaC₂₃H₃₂F₃N₅O₄

Mol. Weight499.534 g/mol

IUPAC(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide

SMILESCC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C

InChIInChI=1S/C23H32F3N5O4/c1-21(2,3)16(30-20(35)23(24,25)26)19(34)31-10-13-14(22(13,4)5)15(31)18(33)29-12(9-27)8-11-6-7-28-17(11)32/h11-16H,6-8,10H2,1-5H3,(H,28,32)(H,29,33)(H,30,35)/t11-,12-,13-,14-,15-,16+/m0/s1

InChI KeyLIENCHBZNNMNKG-OJFNHCPVSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms